SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMASURE (HMSR) - Buyout in the works?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bruce bell who wrote (30)12/2/1997 12:43:00 PM
From: hcm1943  Read Replies (2) of 88
 
it was part of the agreement between HMSR & Novo, if the stock were 60 novo could exchange at 10 1/2 now at 3/4 HMSR can. This will change tangible value by 8.5 million. If burn rate is down and sales to Amer Red Cross are proceeding as expected IMHO this company will be a wonderful investment if you don't pay attention to near term trading swings. I have no input re the Pall litigation
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext